On September 14, we will arrange the 2022 fall edition of BioStock Investor Meeting, where life science companies from a number of therapeutic areas present their business cases to investors and potential partners. Join the live event in person for first-hand-access to information and company representatives.
As an investor, analyst and interested party, you will get the chance to listen to, and mingle with, companies active in the Nordic life science sector in central Stockholm. The program includes companies from a wide range of therapeutic areas and indications, including Arcede Pharma, Brain+, Cereno Scientific, Cyxone, Elicera Therapeutics, Idogen, Lipum, OssDsign, Pharmiva, Redwood Pharma och WntResearch.
We will also listen to experts insights on current stock market conditions and for life science projects in general by Mattias Häggblom, Equity Research Analyst and Sector Head for Nordic life science stocks at Handelsbanken, who will share his view of the market.
Join us for the live event!
The 2022 fall edition of BioStock Investor Meeting will be live with a seated audience. Participating at the live event gives you the opportunity to interact with company representatives and industry professionals.
- Where? 7A Posthuset, Vasagatan 28 in Stockholm
- When? September 14, 2022. Registration from 9am, program 10am-3pm
- Breakfast, lunch, coffee/tea and something sweet to go with, are included in your registration.
The number of slots are limited and pre-registration is required – register now to secure your spot! See you on September 14!